Blincyto Outpatient Community Study.
Research payments
$1,478,507
Through program year 2024, $1,478,507 in research payments was reported against Blincyto Outpatient Community Study., across 72 payments, paid by Amgen Inc..
- Paid by
- Amgen Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
5 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | Research | $84,725 | 21 |
| 2023 | Research | $18,026 | 7 |
| 2022 | Research | $375,945 | 11 |
| 2021 | Research | $984,810 | 32 |
| 2020 | Research | $15,000 | 1 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
8 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Michael Keng Charlottesville, VA Named on 7 payments
- Timothy Pardee Winston Salem, NC Named on 6 payments
- Deepa Jeyakumar Orange, CA Named on 5 payments
- Michal Bar-Natan New York, NY Named on 5 payments
- Hemant Murthy Jacksonville, FL Named on 3 payments
- Juan Varela Orlando, FL Named on 3 payments
- Krishna Gundabolu Omaha, NE Named on 3 payments
- Tulio Rodriguez Maywood, IL Named on 3 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.